§ 13F · FUND PROFILE
Avidity Partners Management LP.
Institutional filer · behavioral pattern: Other. Summary pending.
AUM · — (13F)Positions · 39Turnover · — · Q4Filed · Feb 13, 2026
CONCENTRATION
—
Top 10 holdings
NEW BUYS
0
+$346.7T deployed
EXITS
0
No exits
SECTOR SHIFT
—
No prior quarter data
3YR HIT RATE
—
Top-5 overlap
§ 01 · TOP HOLDINGS
The book · Q4 2025
FILED FEB 13, 2026
| # | Ticker | Name | Shares | $ value | % port | Δ Q4 |
|---|---|---|---|---|---|---|
| 1 | DNTH | DIANTHUS THERAPEUTICS INC | 2.10M | $86.7T | 25.0% | NEW |
| 2 | CGON | CG ONCOLOGY INC | 1.47M | $61.1T | 17.6% | NEW |
| 3 | JBIO | JADE BIOSCIENCES INC | 1.40M | $21.6T | 6.2% | NEW |
| 4 | ORKA | ORUKA THERAPEUTICS INC | 660K | $20.0T | 5.8% | NEW |
| 5 | TEVA | TEVA PHARMACEUTICAL INDS LTD | 417K | $13.0T | 3.8% | NEW |
| 6 | BSX | BOSTON SCIENTIFIC CORP | 115K | $10.9T | 3.1% | NEW |
| 7 | MDT | MEDTRONIC PLC | 108K | $10.3T | 3.0% | NEW |
| 8 | CATX | PERSPECTIVE THERAPEUTICS INC | 3.21M | $8.8T | 2.5% | NEW |
| 9 | ALNY | ALNYLAM PHARMACEUTICALS INC | 21K | $8.4T | 2.4% | NEW |
| 10 | RGEN | REPLIGEN CORP | 50K | $8.2T | 2.4% | NEW |
§ 02 · SECTOR ALLOCATION
Where the money is
Sector data pending
§ 03 · THE AVIDITY SIGNAL
AC read
Avidity Partners Management LP is classified as a Other fund.
Read the full dossier →§ 04 · FILING HISTORY
Q-by-Q deltas
1 FILINGS
Q4 2025
Steady book
+0 buys · −0 exits · 0 changed